# Functional Neuromodulation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/functional-neuromodulation

- Industry: Healthcare
- Headquarters: Toronto, Canada
- Website: www.functionalneuromodulation.com
- Total disclosed funding: $11M
- Latest round: Series A (Oct 17, 2011)
- Investors on record: 2

## About

Functional Neuromodulation is a Toronto-based company specializing in the development and commercialization of neuromodulation therapies aimed at enhancing patient health outcomes through innovative neurological interventions.Founded in 2010 and headquartered in Toronto, Canada, Functional Neuromodulation focuses on creating solutions in the field of neurological health. The company has undergone no notable pivots and operates independently without any known subsidiaries. In October 2011, the company secured USD 10.4 mn in Series A funding from Medtronic plc and Genesys Capital Management, which marked a significant milestone in their funding journey. The firm has successfully completed 2 deals since its inception, with the latest funding round representing the total amount raised, USD 10.4 mn.FunctionalNeuRoModulation.com offers a domain for sale that focuses on creating a digital presence for businesses and individuals within the neuromodulation and functional therapies sectors. The domain acts as a central asset for organizations aiming to establish their online identity in the neuroscience and medical technology fields, serving as a marketing and branding tool that connects them with potential customers and end-users interested in neuromodulation innovations. This offering targets a global customer base, including startups and established entities within North America, Europe, and parts of Asia, which are seeing increasing demand for neuromodulation solutions.The revenue model for FunctionalNeuRoModulation.com is primarily based on the sale of the domain priced at USD 10,295, placing it within a premium market segment. Transactions are conducted through direct purchase agreements with clients, who are businesses or individuals looking to enhance their visibility in this niche industry. Clients may choose flexible payment plans of up to 12 months, enabling broader access to the premium domain ownership. The secure online platform ensures quick access to purchased domains, usually within one to two hours of payment completion, reflecting a direct-to-consumer approach.Looking ahead, Functional Neuromodulation plans to utilize the recent Series A funding of USD 10.4 mn to develop new products and strengthen its market presence. The company aims to expand its offerings in the neuromodulation space, although specific product release dates have not yet been disclosed. Moreover, the firm is considering strategic expansion into additional markets across North America and Europe by 2025, leveraging its recent funding to support these initiatives and enhance its operational capabilities.

## Funding rounds

- Series A, Oct 17, 2011, $10M — Genesys Capital Management, Medtronic plc
- Seed, Nov 1, 2010, $0.6M — Genesys Capital Management

## Investors

- Genesys Capital Management (https://capitalatlas.ai/funds/genesys-capital-management) — Seed, Series A
- Medtronic plc — Series A